JPWO2023163094A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023163094A5 JPWO2023163094A5 JP2024503250A JP2024503250A JPWO2023163094A5 JP WO2023163094 A5 JPWO2023163094 A5 JP WO2023163094A5 JP 2024503250 A JP2024503250 A JP 2024503250A JP 2024503250 A JP2024503250 A JP 2024503250A JP WO2023163094 A5 JPWO2023163094 A5 JP WO2023163094A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- peptide
- seq
- nos
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025147367A JP2025172927A (ja) | 2022-02-25 | 2025-09-05 | 成人ｔ細胞白血病の治療又は予防のための医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022027480 | 2022-02-25 | ||
| PCT/JP2023/006691 WO2023163094A1 (ja) | 2022-02-25 | 2023-02-24 | 成人ｔ細胞白血病の治療又は予防のための医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025147367A Division JP2025172927A (ja) | 2022-02-25 | 2025-09-05 | 成人ｔ細胞白血病の治療又は予防のための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023163094A1 JPWO2023163094A1 (https=) | 2023-08-31 |
| JPWO2023163094A5 true JPWO2023163094A5 (https=) | 2024-10-22 |
Family
ID=87766096
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503250A Pending JPWO2023163094A1 (https=) | 2022-02-25 | 2023-02-24 | |
| JP2025147367A Pending JP2025172927A (ja) | 2022-02-25 | 2025-09-05 | 成人ｔ細胞白血病の治療又は予防のための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025147367A Pending JP2025172927A (ja) | 2022-02-25 | 2025-09-05 | 成人ｔ細胞白血病の治療又は予防のための医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250236642A1 (https=) |
| EP (1) | EP4483894A4 (https=) |
| JP (2) | JPWO2023163094A1 (https=) |
| CN (1) | CN118678966A (https=) |
| WO (1) | WO2023163094A1 (https=) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08151396A (ja) | 1994-11-28 | 1996-06-11 | Teijin Ltd | Ｈｌａ結合性オリゴペプチド及びそれを含有する免疫調節剤 |
| US6524587B1 (en) * | 1998-05-05 | 2003-02-25 | Bruce W. Lyday | Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors |
| EP1339871B1 (en) * | 2000-08-15 | 2008-10-15 | The Johns Hopkins University School Of Medicine | Diagnosis and treatment of tumor-suppressor associated disorders |
| WO2004092373A1 (ja) * | 2003-04-16 | 2004-10-28 | Japan Science And Technology Agency | Ｈｔｌｖ－ｉ特異的ｃｔｌ誘導活性ペプチド |
| WO2006004182A1 (ja) | 2004-07-07 | 2006-01-12 | Nec Corporation | 配列予測システム |
| JP5176099B2 (ja) * | 2004-09-27 | 2013-04-03 | 国立大学法人 東京医科歯科大学 | ＨＬＡ−Ａ１１拘束性Ｔａｘ抗腫瘍エピトープ |
| JP5131946B2 (ja) * | 2005-09-13 | 2013-01-30 | 国立大学法人 東京大学 | がんの診断、処置および／または予防、および／または浸潤・転移の抑制のための方法、システムおよび組成物ならびに関連するスクリーニング方法 |
| EP2069793B9 (en) * | 2006-08-29 | 2017-08-16 | Oxford BioTherapeutics Ltd | Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |
| GB2455634A (en) * | 2007-12-20 | 2009-06-24 | Ucb Pharma Sa | Treatment of cancer |
| CN102341412B (zh) * | 2009-03-05 | 2018-01-05 | 梅达雷克斯有限责任公司 | 特异于cadm1 的全人抗体 |
| WO2012119989A2 (en) * | 2011-03-04 | 2012-09-13 | Oryzon Genomics, S.A. | Methods and antibodies for the diagnosis and treatment of cancer |
| JP5999703B2 (ja) * | 2013-01-09 | 2016-09-28 | 国立大学法人 東京医科歯科大学 | ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ |
| EP3925968A3 (en) * | 2014-10-07 | 2022-03-02 | Cytlimic Inc. | Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell |
| EP3269726B1 (en) * | 2015-03-09 | 2025-05-07 | Nec Corporation | Peptide derived from muc1, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cells |
| CN113388021A (zh) * | 2015-03-09 | 2021-09-14 | Cytlimic公司 | 源于gpc3的肽、使用其的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法 |
| CN109535231B (zh) * | 2018-11-21 | 2021-03-19 | 温州医科大学附属第一医院 | 人T细胞病毒抗原蛋白Tax的CTL特异性识别表位及其应用 |
| JP7593242B2 (ja) | 2020-07-29 | 2024-12-03 | Jsr株式会社 | 液晶配向剤、液晶配向膜及び液晶素子 |
| JPWO2022244801A1 (https=) * | 2021-05-19 | 2022-11-24 |
-
2023
- 2023-02-24 JP JP2024503250A patent/JPWO2023163094A1/ja active Pending
- 2023-02-24 EP EP23760093.7A patent/EP4483894A4/en active Pending
- 2023-02-24 WO PCT/JP2023/006691 patent/WO2023163094A1/ja not_active Ceased
- 2023-02-24 US US18/838,470 patent/US20250236642A1/en active Pending
- 2023-02-24 CN CN202380020568.7A patent/CN118678966A/zh active Pending
-
2025
- 2025-09-05 JP JP2025147367A patent/JP2025172927A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7733703B2 (ja) | ワクチン効力を改善するためのシステム及び方法 | |
| WO2022068850A1 (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| CN100391542C (zh) | 向抗原呈递细胞递送基因的药物组合物及其用途 | |
| EP0941315B1 (en) | Fusion proteins containing stress proteins for inducing immune responses | |
| JP2023540732A5 (https=) | ||
| ES2591029T3 (es) | Péptidos WT-1 inmunogénicos y métodos para su uso | |
| JP2020506690A5 (https=) | ||
| CN109121413A (zh) | 使用靶向核酸纳米载体编程治疗性细胞的组合物和方法 | |
| JP2021502980A5 (https=) | ||
| JP2023522715A (ja) | 細胞ワクチンプラットフォーム及び使用方法 | |
| Gold et al. | Secretion of Nitrite by Schwann Cells and Its Effect on T-Cell Activationin Vitro | |
| JP2008530975A5 (https=) | ||
| RU2012127358A (ru) | Олигопептиды imp-3 и содержащие их вакцины | |
| WO2023129993A2 (en) | Antigen delivery platform and methods of use | |
| AU615940B2 (en) | Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | |
| FR2812087A1 (fr) | Procede de criblage de peptides utilisables en immunotherapie | |
| JP2020117504A5 (https=) | ||
| JPWO2023163094A5 (https=) | ||
| JPH06503833A (ja) | 制御された化学のオリゴマー形態の抗原での免疫応答抑制 | |
| Stein et al. | Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual | |
| JP2024538129A5 (https=) | ||
| JP2012506235A5 (https=) | ||
| RU2011150283A (ru) | Пептиды ттк и вакцины, их содержащие | |
| JPH07502165A (ja) | Ｔリンパ球の限定された個体群に対する抗体を生産する方法、抗体および使用方法 | |
| ES2332532T3 (es) | Epitopos de vih y composicion farmaceutica que los contiene. |